Literature DB >> 27089987

Overcoming treatment resistance in cancer: Current understanding and tactics.

Guang Wu1, George Wilson1, Jacob George1, Christopher Liddle1, Lionel Hebbard2, Liang Qiao3.   

Abstract

Chemotherapy is the standard treatment for many, if not all, metastatic cancers. While chemotherapy is often capable of inducing cell death in tumors leading to shrinkage of the tumor bulk, many patients suffer from recurrence and ultimately death due to resistance. During the last decade, treatment resistance has attracted great attention followed by some seminal discoveries, including sequential mutations, cancer stem cells, and bidirectional inter-conversion of stem and non-stem cancer cell populations. Nevertheless, the successful treatment of cancer will require a considerable refinement of our knowledge concerning treatment resistance. In doing so, we expect that a more informed and refined approach to treat cancer will be developed and this may improve prognosis of cancer patients. In this review, we will discuss the current knowledge concerning the failure of cancer treatments and the potential approaches to overcome therapeutic resistance.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Cancer progression; Cancer stem cells; EMT; EMT transition; Mutation; Treatment resistance

Mesh:

Substances:

Year:  2016        PMID: 27089987     DOI: 10.1016/j.canlet.2016.04.018

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  11 in total

1.  Poor Prognosis Indicated by Venous Circulating Tumor Cell Clusters in Early-Stage Lung Cancers.

Authors:  Vasudha Murlidhar; Rishindra M Reddy; Shamileh Fouladdel; Lili Zhao; Martin K Ishikawa; Svetlana Grabauskiene; Zhuo Zhang; Jules Lin; Andrew C Chang; Philip Carrott; William R Lynch; Mark B Orringer; Chandan Kumar-Sinha; Nallasivam Palanisamy; David G Beer; Max S Wicha; Nithya Ramnath; Ebrahim Azizi; Sunitha Nagrath
Journal:  Cancer Res       Date:  2017-07-17       Impact factor: 12.701

2.  Bitter melon juice exerts its efficacy against pancreatic cancer via targeting both bulk and cancer stem cells.

Authors:  Deepanshi Dhar; Gagan Deep; Sushil Kumar; Michael F Wempe; Komal Raina; Chapla Agarwal; Rajesh Agarwal
Journal:  Mol Carcinog       Date:  2018-05-18       Impact factor: 4.784

3.  The FBXW2-MSX2-SOX2 axis regulates stem cell property and drug resistance of cancer cells.

Authors:  Yuan Yin; Chuan-Ming Xie; Hua Li; Mingjia Tan; Guoan Chen; Rachel Schiff; Xiufang Xiong; Yi Sun
Journal:  Proc Natl Acad Sci U S A       Date:  2019-09-23       Impact factor: 11.205

4.  Chemotherapy-Induced Long Non-coding RNA 1 Promotes Metastasis and Chemo-Resistance of TSCC via the Wnt/β-Catenin Signaling Pathway.

Authors:  Zhaoyu Lin; Lijuan Sun; Shule Xie; Shanyi Zhang; Song Fan; Qunxing Li; Weixiong Chen; Guokai Pan; Weiwei Wang; Bin Weng; Zhang Zhang; Bodu Liu; Jinsong Li
Journal:  Mol Ther       Date:  2018-04-05       Impact factor: 11.454

Review 5.  The role of polyphenols in overcoming cancer drug resistance: a comprehensive review.

Authors:  Parisa Maleki Dana; Fatemeh Sadoughi; Zatollah Asemi; Bahman Yousefi
Journal:  Cell Mol Biol Lett       Date:  2022-01-03       Impact factor: 5.787

Review 6.  The Epigenomics of Embryonic Pathway Signaling in Colorectal Cancer.

Authors:  Curt Balch; Jayaram B Ramapuram; Amit K Tiwari
Journal:  Front Pharmacol       Date:  2017-05-19       Impact factor: 5.810

7.  Primary patient-derived lung adenocarcinoma cell culture challenges the association of cancer stem cells with epithelial-to-mesenchymal transition.

Authors:  Verena Tiran; Joerg Lindenmann; Luka Brcic; Ellen Heitzer; Stefanie Stanzer; Nassim Ghaffari Tabrizi-Wizsy; Elvira Stacher; Herbert Stoeger; Helmut H Popper; Marija Balic; Nadia Dandachi
Journal:  Sci Rep       Date:  2017-08-30       Impact factor: 4.379

Review 8.  Targeting Oxidatively Induced DNA Damage Response in Cancer: Opportunities for Novel Cancer Therapies.

Authors:  Pierpaola Davalli; Gaetano Marverti; Angela Lauriola; Domenico D'Arca
Journal:  Oxid Med Cell Longev       Date:  2018-03-27       Impact factor: 6.543

Review 9.  Actionable Potentials of Less Frequently Mutated Genes in Colorectal Cancer and Their Roles in Precision Medicine.

Authors:  Ryia Illani Mohd Yunos; Nurul Syakima Ab Mutalib; Francis Yew Fu Tieng; Nadiah Abu; Rahman Jamal
Journal:  Biomolecules       Date:  2020-03-20

10.  Patient-Derived, Drug-Resistant Colon Cancer Cells Evade Chemotherapeutic Drug Effects via the Induction of Epithelial-Mesenchymal Transition-Mediated Angiogenesis.

Authors:  Jin Hong Lim; Kyung Hwa Choi; Soo Young Kim; Cheong Soo Park; Seok-Mo Kim; Ki Cheong Park
Journal:  Int J Mol Sci       Date:  2020-10-10       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.